 |
市場調査レポート
商品コード
1461531
神経の修復と再生の世界市場規模、シェア、成長分析、タイプ別、用途別-産業予測、2024～2031年Global Nerve Repair and Regeneration Market Size, Share, Growth Analysis, By Type(Neurostimulation and Neuromodulation Devices, and Biomaterials), By Application(Peripheral Nerve Injury, Epilepsy) - Industry Forecast 2024-2031 |
||||||
| 神経の修復と再生の世界市場規模、シェア、成長分析、タイプ別、用途別-産業予測、2024～2031年 |
|
出版日: 2024年04月01日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
神経の修復と再生の世界市場規模は2022年に82億米ドルと評価され、予測期間（2024～2031年）のCAGRは12.17%で、2023年の92億米ドルから2031年には230億5,000万米ドルに成長する展望です。
パーキンソン病、アルツハイマー病、さまざまな中枢神経系（CNS）障害など、神経疾患の有病率が世界的に高まっていることが、世界市場の上昇傾向に拍車をかけています。このような罹患者の急増は、効果的な治療オプションに対する需要の高まりに拍車をかけています。医療セグメントの主要企業は、この需要の高まりに対応するため、製品パイプラインの強化に積極的に取り組んでおり、神経疾患治療の有効性を高めることを目的とした技術的進歩を推進するための研究開発に多大な努力を傾けています。このような取り組みは、市場の拡大に大きく貢献するものと考えられます。さらに、多様な中枢神経系疾患に対する治療オプションの急増が、市場展望を拡大させています。特に、加工神経移植片を利用した治療法は、上肢の神経障害に悩む患者の運動・知覚神経機能の回復に有望な結果を示しています。米国手外科学会（American Society for Surgery of the Hand）の年次総会で発表された研究では、特定の神経移植片による治療を受けた患者の75％が運動機能の回復を認め、85％が感覚神経機能の回復を経験していることが明らかになりました。さらに、神経疾患に対する一般市民の意識の高まりは、環境の影響、ライフスタイルの選択、遺伝、栄養、身体的損傷などの要因と相まって、これらの疾患に対する理解を深めています。このような意識の高まりは、神経の修復と再生ソリューションに対する需要の高まりに顕著に寄与しています。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模の推定
- 市場の危機と限界
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
神経の修復と再生の世界市場：タイプ別
- 市場概要
- 神経刺激と神経調節装置
- 生体材料
神経の修復と再生の世界市場：用途別
- 市場概要
- 末梢神経損傷
- てんかん
- パーキンソン病
- アルツハイマー病
神経の修復と再生の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic（米国）
- Boston Scientific Corporation（米国）
- Abbott Laboratories（米国）
- Stryker Corporation（米国）
- AxoGen, Inc.（米国）
- Integra LifeSciences Holdings Corporation（米国）
- Baxter International Inc.（米国）
- Nevro Corp（米国）
- LivaNova PLC（英国）
- Cyberonics Inc.（米国）
- Orthofix Medical Inc.（米国）
- Polyganics（オランダ）
- Nuvectra Corporation（米国）
- Polyganics BV（オランダ）
- BioTime Inc.（米国）
- Collagen Matrix, Inc.（米国）
- Synovis Micro Companies Alliance, Inc.（米国）
- StimGuard LLC（米国）
- Nexeon MedSystems Inc.（米国）
- Checkpoint Surgical, Inc.（米国）
Global Nerve Repair And Regeneration Market size was valued at USD 8.2 Billion in 2022 and is poised to grow from USD 9.2 Billion in 2023 to USD 23.05 Billion by 2031, at a CAGR of 12.17% during the forecast period (2024-2031).
The upward trajectory of the global market is fueled by the escalating prevalence of neurological disorders worldwide, including Parkinson's disease, Alzheimer's, and various Central Nervous System (CNS) disorders. This surge in afflicted individuals has spurred a heightened demand for effective treatment options. Major players in the medical sector are actively involved in bolstering their product pipelines to meet this escalating demand, channeling significant efforts into research and development endeavors to drive technological advancements aimed at enhancing the efficacy of neurological disorder treatments. These strides are poised to substantially fuel market expansion. Furthermore, the proliferation of therapeutic options for diverse CNS disorders amplifies market prospects. Notably, therapies utilizing processed nerve allografts have exhibited promising outcomes in reinstating motor and sensory nerve functions among patients grappling with upper extremity nerve impairments. A study presented at the annual meeting of the American Society for Surgery of the Hand revealed that 75% of patients treated with a specific nerve allograft witnessed motor function recovery, with 85% experiencing restored sensory nerve function. Additionally, heightened public awareness regarding neurological disorders, coupled with factors encompassing environmental influences, lifestyle choices, genetics, nutrition, and physical injuries, has cultivated a deeper understanding of these conditions. This augmented awareness has notably contributed to the escalating demand for nerve repair and regeneration solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair And Regeneration Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Nerve Repair And Regeneration Market Segmental Analysis
Global Nerve Repair and Regeneration Market is segmented by Type, application, and region. Based on Type, the market can be segmented into neurostimulation and neuromodulation devices, and biomaterials. Based on application, the market is segmented into peripheral nerve injury, epilepsy, Parkinson's disease, and Alzheimer's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Nerve Repair And Regeneration Market
A major catalyst propelling the nerve repair and regeneration market forward is the escalating prevalence of neurological disorders worldwide, encompassing ailments like Alzheimer's disease, Parkinson's disease, and spinal cord injuries. As the frequency of these conditions rises, there's a pressing requirement for efficient treatment avenues, thus spurring an upsurge in the demand for nerve repair and regeneration therapies. This momentum is fueled by various factors including aging demographics, shifts in lifestyles, environmental impacts, and genetic susceptibilities, all underscoring the imperative for inventive solutions within the market.
Restraints in the Global Nerve Repair And Regeneration Market
A key challenge within the nerve repair and regeneration sector is the substantial expense linked to cutting-edge treatments and therapies. The advancement and adoption of innovative technologies and regenerative approaches necessitate significant investments in research, development, and production. These expenses can create significant hurdles for patients seeking access, particularly in areas with constrained healthcare resources or insufficient insurance coverage. Moreover, the reimbursement environment for nerve repair and regeneration procedures may not consistently favor affordability and accessibility for patients.
Market Trends of the Global Nerve Repair And Regeneration Market
A notable trend in the nerve repair and regeneration sector involves a heightened emphasis on regenerative medicine and stem cell therapies. Both researchers and companies are delving into the capabilities of stem cells to stimulate nerve regrowth and revive neurological functions, presenting a promising avenue for patients grappling with nerve injuries or degenerative conditions. Stem cell-based methods present the opportunity to replenish damaged or lost cells, offering hopeful prospects for innovative treatments tailored to individual needs, thereby indicating the industry's movement towards regenerative and personalized therapeutic approaches.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Nerve Repair and Regeneration Market by Type
- Market Overview
- Neurostimulation and Neuromodulation Devices
- and Biomaterials
Global Nerve Repair and Regeneration Market by Application
- Market Overview
- Peripheral Nerve Injury
- Epilepsy
- Parkinson's Disease
- and Alzheimer's Disease
Global Nerve Repair and Regeneration Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AxoGen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyberonics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Polyganics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nuvectra Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Polyganics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioTime Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Collagen Matrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synovis Micro Companies Alliance, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- StimGuard LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nexeon MedSystems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Checkpoint Surgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
